Clinical Trial Update: Neoadjuvant Taxotere [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial of Taxotere (docetaxel) for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED